PCA
IDXX icon

Pallas Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Pallas Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777K Sell
1,476
-330
-18% -$185K 0.02% 425
2026
Q1 		$1.01M Sell
1,806
-252
-12% -$162K 0.04% 328
2025
Q4 		$1.39M Sell
2,058
-203
-9% -$138K 0.05% 289
2025
Q3 		$1.44M Sell
2,261
-73
-3% -$44.3K 0.05% 263
2025
Q2 		$1.25M Buy
2,334
+1,221
+110% +$584K 0.05% 281
2025
Q1 		$467K Buy
+1,113
New +$483K 0.02% 486

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Pallas Capital Advisors's IDXX Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $185K and leaving 1,476 shares worth $777K. The position accounts for 0.02% of the portfolio, ranked #425.

Pallas Capital Advisors first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.44M in Q3 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Pallas Capital Advisors held 1,476 shares of Idexx Laboratories worth $777K as of Q2 2026.
  • Pallas Capital Advisors sold 330 Idexx Laboratories shares in Q2 2026, an estimated $185K.
  • Idexx Laboratories made up 0.02% of Pallas Capital Advisors's portfolio in Q2 2026, its #425 holding.
  • Pallas Capital Advisors first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Pallas Capital Advisors's Idexx Laboratories position peaked at $1.44M in Q3 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.